Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ) has provided an update.
Lee’s Pharmaceutical Holdings Limited has announced a significant acquisition involving the purchase of assets related to the Alexza Business for US$15 million. This transaction, which involves intellectual property rights, inventories, and equipment, is classified as a discloseable transaction under Hong Kong’s Listing Rules, indicating its substantial impact on the company’s operations and market positioning.
The most recent analyst rating on (HK:0950) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on Lee’s Pharmaceutical Holdings Limited stock, see the HK:0950 Stock Forecast page.
More about Lee’s Pharmaceutical Holdings Limited
Average Trading Volume: 3,147,367
Technical Sentiment Signal: Sell
Current Market Cap: HK$989.2M
For a thorough assessment of 0950 stock, go to TipRanks’ Stock Analysis page.